3M Company Revenue in 2024

3M Company reported $23.1B in revenue for fiscal year 2024. This represents a decline of 29.3% compared to the 2023 figure of $32.7B.

Between 2021 and 2024, 3M's reported revenue dropped from $35.4 billion to $23.1 billion — a $12.3 billion decline that looks alarming until you account for the 2023 spinoff of its healthcare business into a separate public company called Solventum. Strip out the spinoff effect and the underlying industrial business tells a more complicated but less dramatic story of margin pressure and legal reserve-building rather than demand collapse. The $2.8 billion net income figure for 2024 reflects a company still generating substantial cash even while absorbing the costs of two landmark legal settlements. The PFAS water contamination settlement and the Combat Arms Earplug litigation with military veterans each ran into the billions, forcing 3M to set aside reserves that compressed reported earnings over multiple years. Market capitalization of $70 billion represents a significant premium to annual revenue, suggesting investors believe the legal overhang is finite and the underlying business is worth more than near-term earnings imply. 3M's revenue trajectory over the four years through 2024 — $35.4B, $34.2B, $32.7B, $23.1B — shows a company that was already shrinking organically before the spinoff accelerated the headline number downward. The industrial and safety segments face pricing pressure and slower manufacturing activity in key end markets. Consumer segments face competition from lower-cost alternatives in categories where 3M's brand premium has eroded. The company's $70 billion market cap against $23.1 billion in revenue implies a multiple that prices in eventual legal resolution and post-spinoff margin improvement. Whether that optimism is warranted depends almost entirely on how the remaining PFAS liability exposure resolves — an outcome that no financial model can accurately predict and that management has described in deliberately broad terms.